En español
NIDA

NIDA Notes

In This Section

NIDA Notes keeps you up to date on research advances in the causes, consequences, prevention, and treatment of drug abuse and addiction and HIV/AIDS.

Learn more about NIDA Notes

NIDA Notes Category Graphic

Intervention Boosts Treatment Participation, Abstinence Among Depressed Women (July 2012)

Intensive case management was more effective in increasing treatment engagement and reducing alcohol consumption among depressed participants than among those who were not depressed, according to a followup analysis of a substance abuse treatment study involving women on welfare.

NIDA Notes Category Graphic

Program Reduces Recidivism Among Men With Co-occurring Disorders (July 2012)

A modified therapeutic community program designed by NIDA-supported researchers helped Colorado offenders with co-occurring substance use and mental health disorders re-enter their communities and avoid recidivism after release from prison.

NIDA Notes Category Graphic

PhenX Toolkit Provides Standard Measures for Research (July 2012)

NIDA researchers working with human subjects now have a new resource at their fingertips: the PhenX Toolkit’s new Substance Abuse and Addiction (SAA) Collection. The Toolkit is designed to provide standardized measures, vetted and approved by the field, to help researchers compare and combine data from multiple studies.

NIDA Notes Category Graphic

Adolescent Smoking and Drinking at Historic Lows (July 2012)

Rates of adolescent cigarette smoking and alcohol drinking stood at historic lows in 2011, but marijuana use trended upward, according to the Monitoring the Future (MTF) survey.

NIDA Notes Category Graphic

Prenatal Cocaine Exposure Increases Monkeys' Impulsivity Into Adulthood (July 2012)

Prenatal drug exposure can have behavioral effects that last well into adulthood, according to two studies of adult monkeys prenatally exposed to cocaine. In the first study, drug-exposed monkeys exhibited less flexibility than controls in adjusting to changing circumstances; in the second study, drug-exposed males exhibited a greater preference than controls for having rewards right away, a sign of impulsivity.

NIDA Notes Category Graphic

Training Gaps for Evidence-Based Practices (July 2012)

Ninety percent of privately funded substance abuse treatment programs in the United States offer cognitive behavioral therapy (CBT)...

NIDA Notes Category Graphic

More Convenient Preparations of Buprenorphine Pass Test (July 2012)

Soluble-film preparations of buprenorphine suppressed heroin abusers’ withdrawal symptoms with no serious side effects in a recent clinical trial. They dissolved more rapidly in the mouth than the pill form of the medication, providing faster relief.

NIDA Notes Category Graphic

The Present and Promise of mHealth (July 2012)

NIDA researchers have developed a computer program that motivates and encourages treatment-seeking when an individual is in a primary care physician’s waiting room. Users of the program, called Video Doctor, enter information on a portable device and receive feedback about health risks related to their drug abuse, along with advice, immediately prior to seeing their physician.

NIDA Notes Category Graphic

Prevention System Has Lasting Effects, Benefit Exceeds Costs (July 2012)

Towns that implemented a drug abuse prevention program called Communities That Care will see a return of $5.30 for each $1 they invested during the 5-year trial of the intervention, according to a cost-benefit analysis. The estimate is based on reductions in smoking and delinquency observed during the fourth year of the study among eighth-graders and the projected total costs of smoking, delinquency, and crime avoided over the lifetimes of study participants.

NIDA Notes Category Graphic

Buprenorphine During Pregnancy Reduces Neonate Distress (July 2012)

Sublingual buprenorphine is a safe and effective alternative to methadone for treating opioid dependence during pregnancy, finds the Maternal Opioid Treatment: Human Experimental Research (MOTHER) study, a NIDA-supported clinical trial. Women who received either medication had similar pregnancy and birth outcomes, but infants born to women who received buprenorphine had milder symptoms of neonatal opioid withdrawal.

Pages

Get this Publication

    Subscribe to NIDA Notes

     

    Get Articles Via RSS

    New Animation

    graphic of a brain using cocaine

    The Rise and Fall of the Cocaine High

    Latest Podcast

    Researchers Speak: Dr. Kevin M. Gray